These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23329232)

  • 1. Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.
    Ali HR; Irwin M; Morris L; Dawson SJ; Blows FM; Provenzano E; Mahler-Araujo B; Pharoah PD; Walton NA; Brenton JD; Caldas C
    Br J Cancer; 2013 Feb; 108(3):602-12. PubMed ID: 23329232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
    Bankhead P; Fernández JA; McArt DG; Boyle DP; Li G; Loughrey MB; Irwin GW; Harkin DP; James JA; McQuaid S; Salto-Tellez M; Hamilton PW
    Lab Invest; 2018 Jan; 98(1):15-26. PubMed ID: 29251737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays.
    Laurinaviciene A; Dasevicius D; Ostapenko V; Jarmalaite S; Lazutka J; Laurinavicius A
    Diagn Pathol; 2011 Sep; 6():87. PubMed ID: 21943197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer Aided Semi-Automated Evaluation of HER2 Immunodetection--A Robust Solution for Supporting the Accuracy of Anti HER2 Therapy.
    Micsik T; Kiszler G; Szabó D; Krecsák L; Hegedűs C; Tibor K; Molnár B
    Pathol Oncol Res; 2015 Sep; 21(4):1005-11. PubMed ID: 25788005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
    Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
    Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms.
    Ahern TP; Beck AH; Rosner BA; Glass B; Frieling G; Collins LC; Tamimi RM
    J Clin Pathol; 2017 May; 70(5):428-434. PubMed ID: 27729430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 expression and triple negative profile in breast carcinoma.
    Kallel-Bayoudh I; Hassen HB; Khabir A; Boujelbene N; Daoud J; Frikha M; Sallemi-Boudawara T; Aifa S; Rebaï A
    Med Oncol; 2011 Dec; 28 Suppl 1():S55-61. PubMed ID: 20890735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.
    Bolton KL; Garcia-Closas M; Pfeiffer RM; Duggan MA; Howat WJ; Hewitt SM; Yang XR; Cornelison R; Anzick SL; Meltzer P; Davis S; Lenz P; Figueroa JD; Pharoah PD; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):992-9. PubMed ID: 20332278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
    Allott EH; Geradts J; Sun X; Cohen SM; Zirpoli GR; Khoury T; Bshara W; Chen M; Sherman ME; Palmer JR; Ambrosone CB; Olshan AF; Troester MA
    Breast Cancer Res; 2016 Jun; 18(1):68. PubMed ID: 27349894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
    Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
    Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays.
    Akbar S; Jordan LB; Purdie CA; Thompson AM; McKenna SJ
    Br J Cancer; 2015 Sep; 113(7):1075-80. PubMed ID: 26348443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis.
    Gustavson MD; Bourke-Martin B; Reilly D; Cregger M; Williams C; Mayotte J; Zerkowski M; Tedeschi G; Pinard R; Christiansen J
    Arch Pathol Lab Med; 2009 Sep; 133(9):1413-9. PubMed ID: 19722747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
    Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
    BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer.
    Krecsák L; Micsik T; Kiszler G; Krenács T; Szabó D; Jónás V; Császár G; Czuni L; Gurzó P; Ficsor L; Molnár B
    Diagn Pathol; 2011 Jan; 6():6. PubMed ID: 21244664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry.
    Helin HO; Tuominen VJ; Ylinen O; Helin HJ; Isola J
    Virchows Arch; 2016 Feb; 468(2):191-8. PubMed ID: 26493985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
    Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
    Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer.
    Masmoudi H; Hewitt SM; Petrick N; Myers KJ; Gavrielides MA
    IEEE Trans Med Imaging; 2009 Jun; 28(6):916-25. PubMed ID: 19164073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-assisted assessment of the human epidermal growth factor receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls.
    Hall BH; Ianosi-Irimie M; Javidian P; Chen W; Ganesan S; Foran DJ
    BMC Med Imaging; 2008 Jun; 8():11. PubMed ID: 18534031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.
    Clark SE; Warwick J; Carpenter R; Bowen RL; Duffy SW; Jones JL
    Br J Cancer; 2011 Jan; 104(1):120-7. PubMed ID: 21139586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.
    Rizzardi AE; Zhang X; Vogel RI; Kolb S; Geybels MS; Leung YK; Henriksen JC; Ho SM; Kwak J; Stanford JL; Schmechel SC
    Diagn Pathol; 2016 Jul; 11(1):63. PubMed ID: 27401406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.